Titilade Kehinde Ayandeyi Teibo, Rubia Laine de Paula Andrade, Rander Junior Rosa, Paula Daniella de Abreu, Oluwaseyi Ademo Olayemi, Yan Mathias Alves, Reginaldo Bazon Vaz Tavares, Fernanda Bruzadelli Paulino da Costa, Heriederson Sávio Dias Moura, Letícia Perticarrara Ferezin, Ariela Fehr Tártaro, Mônica Chiodi Toscano de Campos, Natacha Martins Ribeiro, Thaís Zamboni Berra, Ricardo Alexandre Arcêncio
This study evaluated the barriers that interfere with access to diagnosis and treatment of tuberculosis (TB) from the perspective of the patient and health professionals globally. Using the PICo acronym, the question we asked was "What are the barriers that interfere with access to tuberculosis diagnosis and treatment (I) from the perspective of patients and/or health professionals (P) across countries globally (Co)?". We searched the following databases: EMBASE, Scopus, MEDLINE, Latin American and Caribbean Literature in Health Sciences (LILACS), and Web of Science...
July 18, 2024: ACS Infectious Diseases